Circle Pharma raises $66 Million in Series C Financing

Jun 16, 2021 · South San Francisco, CA, June 16, 2021, — Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today …

CouponFollow Extension

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · South San Francisco, CA, June 16, 2021, — Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today …

circlepharma.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)--Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, …

businesswire.com

$66
OFF

Alliance Of Chief Executives - Circle Pharma Raises $66 Million In ...

1 week from now

Circle Pharma Raises $66 Million in Series C Financing June 16, 2021 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, Inc., a macrocycle drug discovery …

allianceofceos.com

$66
OFF

Wilson Sonsini Advises Circle Pharma On $66 Million Series C …

1 week from now

On June 16, 2021, Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, announced that it has raised $66 million in an …

wsgr.com

$66
OFF

Circle Pharma, Inc. Announced That It Has Received $66 Million In ...

1 week from now

On June 16, 2021, Circle Pharma, Inc. closed the transaction. The company issued 77,647,059 Series C Preferred Stocks for gross proceeds of $66,000,000 in the transaction co-led by …

marketscreener.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $66 million in an …

marketscreener.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, …

biospace.com

$66000000
OFF

Series C - Circle Pharma - 2021-06-16 - Crunchbase

1 week from now

Jun 16, 2021 · Circle Pharma raised $66000000 on 2021-06-16 in Series C

crunchbase.com

$66
OFF

Wilson Sonsini Advises Circle Pharma On $66 Million Series C …

1 week from now

On June 16, 2021, Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, announced that it has raised $66 million in an …

wsgr.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $66 million in an oversubscribed …

medtechalert.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced …

mbn.media

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · SOUTH SAN FRANCISCO, Calif.– (BUSINESS WIRE)–Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable …

circlepharma.com

$45
OFF

Circle Pharma Raises $45 Million In Series B Financing

1 week from now

Mar 17, 2020 · South San Francisco, CA, March 17, 2020, — Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today …

circlepharma.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced …

preipopharma.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $66 million in an oversubscribed …

pharmasources.com

$90
OFF

Circle Pharma Closes $90M Series D Financing - FinSMEs

1 week from now

Sep 3, 2024 · Circle Pharma, a San Francisco, CA-based clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class …

finsmes.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

SOUTH SAN FRANCISCO, Calif. – Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, announced that it has raised $66 …

checkorphan.org

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, announced that it …

allianceofceos.com

FAQs about Circle Pharma raises $66 Million in Series C Financing Coupon?

What is circle Pharma doing with cyclin-targeted peptides?

Circle Pharma has raised $66 million to take cyclin-targeted programs toward clinical development. The Eli Lilly-backed series C round sets Circle up to build on its years of research into cell-permeable macrocyclic peptide therapeutics with the potential to hit previously undruggable targets. ...

How much money has Circle added to its bank balance?

Now, with clinical development on the horizon, Circle has added another $66 million to its bank balance in a series C round. The Column Group and Nextech Invest co-led the round with the support of new investors including Euclidean Capital, Pavillion Capital, Hartford HealthCare Endowment and Lilly. ...

What is a circle drug & how does it work?

Specifically, Circle sees its drugs as ways to hit targets that lack binding sites for small molecules and are hidden from biologics inside cells. Unlike those modalities, macrocycles may be able to enter cells to inhibit processes such as protein-protein interactions. ...